1
Pisters, R., van Vugt, S. P. G., Brouwer, M. A., Elvan, A., ten Holt, W. L., Zwart, P. A. G., Kirchhof, P., Crijns, H. J. G. M., Hemels, M. E. W.
Veröffentlicht in: Pisters , R , van Vugt , S P G , Brouwer , M A , Elvan , A , ten Holt , W L , Zwart , P A G , Kirchhof , P , Crijns , H J G M & Hemels , M E W 2017 , ' Real-life use of Rivaroxaban in the Netherlands : data from the Xarelto for Prevention of Stroke in Patients with Atrial Fibrillation (XANTUS) registry ' , Netherlands Heart Journal , vol. 25 , no. 10 , pp. 551-558 . https://doi.org/10.1007/s12471-017-1009-9;
2017
Veröffentlicht in: Pisters , R , van Vugt , S P G , Brouwer , M A , Elvan , A , ten Holt , W L , Zwart , P A G , Kirchhof , P , Crijns , H J G M & Hemels , M E W 2017 , ' Real-life use of Rivaroxaban in the Netherlands : data from the Xarelto for Prevention of Stroke in Patients with Atrial Fibrillation (XANTUS) registry ' , Netherlands Heart Journal , vol. 25 , no. 10 , pp. 551-558 . https://doi.org/10.1007/s12471-017-1009-9;
2017
2
Lisa A. de Jong, Judith J. Gout-Zwart, Jelena Stevanovic, Harrie Rila, Mike Koops, Menno V. Huisman, Maarten J. Postma
Veröffentlicht in: TH Open, Vol 02, Iss 03, Pp e315-e324 (2018);
2018
Veröffentlicht in: TH Open, Vol 02, Iss 03, Pp e315-e324 (2018);
2018
3
Jacobs, M S, van Leent, M W J, Tieleman, R G, Jansman, F G A, Cao, Q, Postma, M J, van Hulst, M
Veröffentlicht in: Jacobs , M S , van Leent , M W J , Tieleman , R G , Jansman , F G A , Cao , Q , Postma , M J & van Hulst , M 2017 , ' Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in the Netherlands ' , Journal of Medical Economics , vol. 20 , no. 12 , pp. 1231-1236 . https://doi.org/10.1080/13696998.2017.1363766;
2017
Veröffentlicht in: Jacobs , M S , van Leent , M W J , Tieleman , R G , Jansman , F G A , Cao , Q , Postma , M J & van Hulst , M 2017 , ' Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in the Netherlands ' , Journal of Medical Economics , vol. 20 , no. 12 , pp. 1231-1236 . https://doi.org/10.1080/13696998.2017.1363766;
2017
4
Jacobs, Maartje S, Schouten, Jeroen F, de Boer, Pieter T, Hoffmann, Mikael, Levin, Lars-Åke, Postma, Maarten J
Veröffentlicht in: Jacobs , M S , Schouten , J F , de Boer , P T , Hoffmann , M , Levin , L-Å & Postma , M J 2018 , ' Secondary adherence to non-vitamin-K antagonist oral anticoagulants in patients with atrial fibrillation in Sweden and the Netherlands ' , Current Medical Research and Opinion , vol. 34 , no. 10 , pp. 1839-1847 . https://doi.org/10.1080/03007995.2018.1459528;
2018
Veröffentlicht in: Jacobs , M S , Schouten , J F , de Boer , P T , Hoffmann , M , Levin , L-Å & Postma , M J 2018 , ' Secondary adherence to non-vitamin-K antagonist oral anticoagulants in patients with atrial fibrillation in Sweden and the Netherlands ' , Current Medical Research and Opinion , vol. 34 , no. 10 , pp. 1839-1847 . https://doi.org/10.1080/03007995.2018.1459528;
2018
5
de Jong, Lisa A, Dvortsin, Evgeni, Janssen, Kristel J., Postma, Maarten J.
Veröffentlicht in: de Jong , L A , Dvortsin , E , Janssen , K J & Postma , M J 2017 , ' Cost-effectiveness Analysis for Apixaban in the Acute Treatment and Prevention of Venous Thromboembolism in the Netherlands ' , Clinical Therapeutics , vol. 39 , no. 2 , pp. 288-302 . https://doi.org/10.1016/j.clinthera.2016.12.012;
2017
Veröffentlicht in: de Jong , L A , Dvortsin , E , Janssen , K J & Postma , M J 2017 , ' Cost-effectiveness Analysis for Apixaban in the Acute Treatment and Prevention of Venous Thromboembolism in the Netherlands ' , Clinical Therapeutics , vol. 39 , no. 2 , pp. 288-302 . https://doi.org/10.1016/j.clinthera.2016.12.012;
2017
6
Le, H.H., Pechlivanoglou, P., Postma, M.J.
Veröffentlicht in: Le , H H , Pechlivanoglou , P & Postma , M J 2013 , ' Indirect treatment comparison and economic evaluation of novel oral anticoagulants for the prevention of stroke in patients with atrial fibrillation in the Netherlands ' , Value in Health , vol. 16 , no. 7 , pp. A514 . https://doi.org/10.1016/j.jval.2013.08.1213;
2013
Veröffentlicht in: Le , H H , Pechlivanoglou , P & Postma , M J 2013 , ' Indirect treatment comparison and economic evaluation of novel oral anticoagulants for the prevention of stroke in patients with atrial fibrillation in the Netherlands ' , Value in Health , vol. 16 , no. 7 , pp. A514 . https://doi.org/10.1016/j.jval.2013.08.1213;
2013
7
De Jong, Lisa A., Gout-Zwart, Judith J., Stevanovic, Jelena, Rila, Harrie, Koops, Mike, Huisman, Menno V., Postma, Maarten J.
Veröffentlicht in: De Jong , L A , Gout-Zwart , J J , Stevanovic , J , Rila , H , Koops , M , Huisman , M V & Postma , M J 2018 , ' Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands : Clinical and Economic Effects ' , BMJ Open , vol. 2 , no. 3 , pp. e315-e324 . https://doi.org/10.1055/s-0038-1672185;
2018
Veröffentlicht in: De Jong , L A , Gout-Zwart , J J , Stevanovic , J , Rila , H , Koops , M , Huisman , M V & Postma , M J 2018 , ' Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands : Clinical and Economic Effects ' , BMJ Open , vol. 2 , no. 3 , pp. e315-e324 . https://doi.org/10.1055/s-0038-1672185;
2018
8
Stevanovic, Jelena, Pompen, Marjolein, Le, Hoa H., Rozenbaum, Mark H., Tieleman, Robert G., Postma, Maarten J.
Veröffentlicht in: Stevanovic , J , Pompen , M , Le , H H , Rozenbaum , M H , Tieleman , R G & Postma , M J 2014 , ' Economic evaluation of apixaban for the prevention of stroke in non-valvular atrial fibrillation in the Netherlands ' , PLoS ONE , vol. 9 , no. 8 , e103974 . https://doi.org/10.1371/journal.pone.0103974;
2014
Veröffentlicht in: Stevanovic , J , Pompen , M , Le , H H , Rozenbaum , M H , Tieleman , R G & Postma , M J 2014 , ' Economic evaluation of apixaban for the prevention of stroke in non-valvular atrial fibrillation in the Netherlands ' , PLoS ONE , vol. 9 , no. 8 , e103974 . https://doi.org/10.1371/journal.pone.0103974;
2014